Athira Pharma Stock Performance
| ATHA Stock | USD 4.42 0.19 4.12% |
On a scale of 0 to 100, Athira Pharma holds a performance score of 4. The firm shows a Beta (market volatility) of 2.01, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Athira Pharma will likely underperform. Please check Athira Pharma's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Athira Pharma's price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Athira Pharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical indicators, Athira Pharma sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 91.2 M | |
| Total Cashflows From Investing Activities | 54.8 M |
Athira Pharma Relative Risk vs. Return Landscape
If you would invest 405.00 in Athira Pharma on August 26, 2025 and sell it today you would earn a total of 37.00 from holding Athira Pharma or generate 9.14% return on investment over 90 days. Athira Pharma is currently generating 0.2343% in daily expected returns and assumes 4.5528% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Athira, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Athira Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Athira Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Athira Pharma, and traders can use it to determine the average amount a Athira Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0515
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATHA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Athira Pharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Athira Pharma by adding it to a well-diversified portfolio.
Athira Pharma Fundamentals Growth
Athira Stock prices reflect investors' perceptions of the future prospects and financial health of Athira Pharma, and Athira Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Athira Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.42 | |||
| Current Valuation | (6.15 M) | |||
| Shares Outstanding | 3.94 M | |||
| Price To Book | 0.68 X | |||
| EBITDA | (95.81 M) | |||
| Cash And Equivalents | 252.4 M | |||
| Cash Per Share | 6.67 X | |||
| Total Debt | 1.22 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 6.79 X | |||
| Cash Flow From Operations | (97.17 M) | |||
| Earnings Per Share | (9.67) X | |||
| Total Asset | 58.78 M | |||
| Retained Earnings | (406.15 M) | |||
About Athira Pharma Performance
By analyzing Athira Pharma's fundamental ratios, stakeholders can gain valuable insights into Athira Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Athira Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Athira Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company was incorporated in 2011 and is headquartered in Bothell, Washington. Athira Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.Things to note about Athira Pharma performance evaluation
Checking the ongoing alerts about Athira Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Athira Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Athira Pharma had very high historical volatility over the last 90 days | |
| Athira Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Athira Pharma currently holds about 252.4 M in cash with (97.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Athira Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Athira Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Athira Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Athira Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Athira Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Athira Pharma's stock. These opinions can provide insight into Athira Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Athira Stock analysis
When running Athira Pharma's price analysis, check to measure Athira Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira Pharma is operating at the current time. Most of Athira Pharma's value examination focuses on studying past and present price action to predict the probability of Athira Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira Pharma's price. Additionally, you may evaluate how the addition of Athira Pharma to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |